Patient Support Line 1-866-433-8000, Monday - Friday: 8:00 AM to 8:00 PM ET
AI, aromatase inhibitor; HER2-, human epidermal growth factor receptor 2-negative; HR+, hormone receptor-positive.
AI, un inhibidor de la aromatasa; HER2-, factor de crecimiento epidérmico humano 2 negativo; HR+, receptor hormonal positivo.
AI, un inhibidor de la aromatasa; HER2-, factor de crecimiento epidérmico humano 2 negativo; HR+, receptor hormonal positivo.
KISQALI + an AI is proven to help reduce the risk of cancer coming back*
*KISQALI + an AI cut the risk of cancer coming back by 25% compared to an AI alone. At 3 years, 91% of people taking KISQALI + AI were cancer-free, compared with 88% of people taking an AI alone, a difference of 3%.
When Erika was diagnosed with early breast cancer, she wanted to do more to help reduce her risk of breast cancer from coming back*
See how with KISQALI + an AI, she's doing more today to help protect tomorrow.
For patients like you with early breast cancer, consider KISQALI + an AI
Watch Maya's story to see how reducing the risk of your cancer coming back can mean more to live for.*